Heparin Sodium Injection, Solution
Product Images NDC 81952-116

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 81952-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hepalink Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Heparin Chemical Structure (Heparin Str)

Chemical structure diagram showing various sugar and sulfate groups, representing the active ingredient Heparin Sodium. The diagram includes multiple hexose sugar rings with attached groups such as -OSO3-, -OH, and carboxylate groups, illustrating the molecular components of Heparin Sodium.*

FDA Label Image

Heparin-fig1 (Heparin Fig1)

Heparin Sodium Injection, USP 5,000 USP Units/mL in a 1 mL multiple dose vial. Label highlights that it is for intravenous or subcutaneous use and not for lock flush. The product is derived from porcine intestinal mucosa, sterile and nonpyrogenic, manufactured for Hepalink USA Inc. in China. Storage instructions specify 20° to 25°C (68° to 77°F).*

FDA Label Image

Heparin-fig2 (Heparin Fig2)

Packaging label for Heparin Sodium Injection USP, 5,000 Units/mL, in 1 mL multiple dose vials. The label shows the drug is for intravenous or subcutaneous use and is not for lock flush. It is distributed by Hepalink USA Inc. and derived from porcine intestinal mucosa. The label features orange, black, and white colors and includes usage and storage instructions.*

FDA Label Image

Heparin-fig3 (Heparin Fig3)

Label for Heparin Sodium Injection, USP 2,000 USP Units per 2 mL (1,000 USP Units per mL) single dose vial by Hepalink USA Inc. The label states it is preservative free, not for lock flush, for intravenous or subcutaneous use, and derived from porcine intestinal mucosa. It includes storage instructions (20 to 25°C), manufacturing origin (China), lot and expiration fields, and barcode.*

FDA Label Image

Heparin-fig4 (Heparin Fig4)

Heparin Sodium 2,000 USP Units/2 mL (1,000 USP Units/mL) Injection, USP in single dose vials. The label indicates it is preservative-free and for intravenous or subcutaneous use. Distributed by Hepalink USA Inc., this product is derived from porcine intestinal mucosa. The packaging includes storage instructions and a warning that the container closure is not made from natural rubber latex.*

FDA Label Image

Heparin-fig5 (Heparin Fig5)

Label for Heparin Sodium Injection, USP 1,000 USP Units/mL in a 1 mL multiple dose vial. The label highlights that it is not for lock flush and is intended for intravenous or subcutaneous use. It specifies storage conditions, states the product is sterile and nonpyrogenic, derived from porcine intestinal mucosa, manufactured in China, and labeled by Hepalink USA Inc.*

FDA Label Image

Heparin-fig6 (Heparin Fig6)

Heparin Sodium 1,000 USP Units/mL injection, solution for intravenous or subcutaneous use, supplied in 1 mL multiple dose vials. The label includes the Hepalink USA Inc. distributor information and a warning note stating NOT FOR LOCK FLUSH. The product is presented in a box labeled with strength, dosage form, and manufacturer details, with a yellow, white, black, and red color scheme.*

FDA Label Image

Heparin-fig7 (Heparin Fig7)

Label for Heparin Sodium Injection, USP, 10,000 USP Units/10 mL (1,000 USP Units/mL) multi-dose vial by Hepalink USA Inc. The label states it is for intravenous or subcutaneous use and includes storage instructions. It also warns: Not for lock flush.*

FDA Label Image

Heparin-fig8 (Heparin Fig8)

Heparin Sodium 10,000 USP Units per 10 mL injection solution label for intravenous or subcutaneous use, distributed by Hepalink USA Inc. The label indicates the product is derived from porcine intestinal mucosa and comes in 25 multiple dose vials. The label includes warnings such as 'Not for Lock Flush' and detailed storage and usage instructions.*

FDA Label Image

Heparin-fig9 (Heparin Fig9)

Label for Heparin Sodium Injection, USP 10,000 USP units/mL in a 1 mL multiple dose vial. The injection is for intravenous or subcutaneous use. It is derived from porcine intestinal mucosa, sterile, nonpyrogenic, and manufactured in China for Hepalink USA Inc. Storage temperature is 20 to 25°C (68 to 77°F). The label includes lot and expiration date fields.*

FDA Label Image

Heparin-fig10 (Heparin Fig10)

Heparin Sodium USP 10,000 Units/mL injection, solution label for 1 mL multiple dose vials by Hepalink USA Inc. The packaging indicates it is for intravenous or subcutaneous use, not for lock flush, and derived from porcine intestinal mucosa. The distribution origin is China and the label includes storage instructions and a barcode.*

FDA Label Image

Heparin-fig11 (Heparin Fig11)

Label for Heparin Sodium Injection USP, 20,000 USP Units/mL, multiple dose vial with 1 mL volume. The label states it is for intravenous or subcutaneous use, not for lock flush. It is derived from porcine intestinal mucosa, sterile, nonpyrogenic, and manufactured in China for Hepalink USA Inc. Storage instructions specify 20° to 25°C (68° to 77°F).*

FDA Label Image

Heparin-fig12 (Heparin Fig12)

Packaging label for Heparin Sodium Injection, USP 20,000 Units/mL by Techdow, a Hepalink Company. The label indicates a 1 mL multiple dose vial for intravenous or subcutaneous use, derived from porcine intestinal mucosa. The label includes storage instructions, ingredient information, and distributor Hepalink USA Inc., with a country of origin as China. The design features magenta and black color blocks with prominent warnings that the vial is not for lock flush.*

FDA Label Image

Heparin-fig13 (Heparin Fig13)

Label for Heparin Sodium Injection, USP, 30,000 USP Units per 30 mL (1,000 USP Units/mL) multiple dose vial. It is for intravenous or subcutaneous use and is not for lock flush. The label states it is derived from porcine intestinal mucosa and is sterile, nonpyrogenic. The product is manufactured in China for Hepalink USA Inc. and distributed by Techdow.*

FDA Label Image

Heparin-fig14 (Heparin Fig14)

Heparin Sodium 30,000 USP Units per 30 mL injection, solution vial packaging label. The label features purple and black color blocks with white and red text stating 'NOT FOR LOCK FLUSH.' Distributed by Hepalink USA Inc., the vial contains 30 mL for intravenous or subcutaneous use in multiple dose vials. The label includes manufacturer information as Techdow USA and warnings about sterile, nonpyrogenic content and storage instructions. The product is derived from porcine intestinal mucosa.*

FDA Label Image

Heparin-fig 15 (Heparin Fig15)

Heparin Sodium Injection, USP label showing 50,000 units in 5 mL (10,000 USP units/mL) multiple dose vial. It is indicated for intravenous (IV) or subcutaneous (SC) use. The vial is manufactured in China for Hepalink USA Inc. The label includes storage instructions (20° to 25°C), nonpyrogenic and sterile status, and a caution 'NOT FOR LOCK FLUSH.'*

FDA Label Image

Heparin-fig16 (Heparin Fig16)

Heparin Sodium Injection, USP 50,000 USP Units/5 mL (10,000 USP Units/mL) multiple dose vial label by Techdow USA, a Hepalink Company. The label indicates the product is for intravenous or subcutaneous use, contains 25 multiple dose vials, and is derived from porcine intestinal mucosa. The label includes storage instructions, manufacturer information, barcode, and a red circle stating NOT FOR LOCK FLUSH.*

FDA Label Image

Heparin-fig17 (Heparin Fig17)

Label for Heparin Sodium Injection, USP, 50,000 USP Units per 10 mL (5,000 USP Units/mL) in a 10 mL multiple dose vial by Hepalink USA Inc. It is indicated for intravenous or subcutaneous use and contains benzyl alcohol as a preservative. The label includes storage instructions, barcode, and manufacturer information.*

FDA Label Image

Heparin-fig18 (Heparin Fig18)

Heparin Sodium 50,000 Units/10 mL injection, solution label from Techdow USA, a Hepalink Company. The label indicates the product is for intravenous or subcutaneous use and contains 10 mL multiple dose vials. It includes warnings about benzyl alcohol and states it is derived from porcine intestinal mucosa. The label features a prominent orange and black design with a red circle warning 'NOT FOR LOCK FLUSH.' Distributed by Hepalink USA Inc., the label includes storage instructions and barcode details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.